Fushine's profit surge, dividends, and new patent drive gains
First-half profit surge Fushine expects first-half net profit to jump 2,487% to 3,204% year-on-year, one of the strongest earnings rebounds on ChiNext. This huge profit growth makes the stock more attractive to investors and supports a higher share price.
This is the core fundamental driver behind the stock's recent strength.
Interim cash dividend proposed Controlling shareholder Bao Jianhua proposed a 2026 interim cash dividend of 0.5 yuan per 10 shares. Returning cash to shareholders signals confidence and can attract income-focused investors, helping support the stock price.
Dividend announcements are a direct capital return event that can lift investor sentiment.
Japanese patent for protein technology Fushine won a Japanese invention patent for its Fusarium oxysporum mycelial protein technology, adding to patents already held in China, South Korea, and the US. This strengthens its position in the fast-growing alternative protein market and supports long-term growth prospects.
The patent expands the company's technology moat and international business potential.
Q3 profit forecast turns positive Fushine expects first-three-quarter net profit of 350-430 million yuan, up 658-785% year-on-year, swinging from a loss to a profit. This confirms the strong earnings trend is continuing beyond the first half, giving investors more confidence.
The Q3 forecast extends the profit recovery story and reinforces the positive earnings trajectory.